ArticleBiology methods & protocols2025
CATHe2: Enhanced CATH superfamily detection using ProstT5 and structural alphabets.
Article in Biology methods & protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The CATH database is a free publicly available online resource that provides annotations about the evolutionary and structural relationships of protein domains. Due to the flux of protein structures coming mainly from the recent breakthrough of AlphaFold and therefore the non-feasibility of manual intervention, the CATH team recently developed an automatic CATH superfamily (SF) classifier called CATHe, which uses a feed-forward neural network (FNN) classifier with protein Language Model (pLM) embeddings as input. Using the same dataset of remote homologues (with a 20% sequence identity threshold), this paper presents CATHe2, which improves on CATHe by switching the old pLM ProtT5 for one of the most recent versions called ProstT5, and by incorporating domain 3D information into the classifier through Structural Alphabet representation, specifically, 3Di sequence embeddings. Finally, CATHe2 implements a new version of the FNN classifier architecture, fine-tuned to perform at the CATH superfamily prediction task. The best CATHe2 model reaches an accuracy of 92.2% ± 0.7% with an F1 score of 82.3% ± 1.3%, which constitutes an improvement of 9.9% on the F1 score and 6.6% on the accuracy, from the previous CATHe version (85.6% ± 0.4% accuracy and 72.4% ± 0.7% F1 score) on its largest dataset (∼1700 superfamilies). This model uses ProstT5 amino acid (AA) sequence and 3Di sequence embeddings as input to the classifier, but a simplified version requiring only AA sequences, already improves CATHe's F1 score by 6.7% ± 1.3% and accuracy by 6.6% ± 0.7% on its largest dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.